156 related articles for article (PubMed ID: 32364253)
1. In vivo evaluation of Vivere bovine pericardium valvular bioprosthesis with a new anti-calcifying treatment.
Braile-Sternieri MCVB; Goissis G; Giglioti AF; Ramirez VDA; Pereira NP; de Vasconcellos A; Basso-Frazzato GG; Braile DM
Artif Organs; 2020 Nov; 44(11):E482-E493. PubMed ID: 32364253
[TBL] [Abstract][Full Text] [Related]
2. In vitro properties and performance of glutaraldehyde-crosslinked bovine pericardial bioprostheses treated with glutamic acid.
Braile MC; Carnevalli NC; Goissis G; Ramirez VA; Braile DM
Artif Organs; 2011 May; 35(5):497-501. PubMed ID: 21595718
[TBL] [Abstract][Full Text] [Related]
3. Anticalcification effects of decellularization, solvent, and detoxification treatment for genipin and glutaraldehyde fixation of bovine pericardium.
Lim HG; Kim SH; Choi SY; Kim YJ
Eur J Cardiothorac Surg; 2012 Feb; 41(2):383-90. PubMed ID: 21683607
[TBL] [Abstract][Full Text] [Related]
4. The Immune Responses and Calcification of Bioprostheses in the α1,3-Galactosyltransferase Knockout Mouse.
Sung Jeong W; Jin Kim Y; Lim HG; Jung S; Ryul Lee J
J Heart Valve Dis; 2016 Mar; 25(2):253-261. PubMed ID: 27989076
[TBL] [Abstract][Full Text] [Related]
5. Combined anti-calcification treatment of bovine pericardium with amino compounds and solvents.
Chang HW; Kim SH; Kim KH; Kim YJ
Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):903-7. PubMed ID: 21388989
[TBL] [Abstract][Full Text] [Related]
6. Biostability, durability and calcification of cryopreserved human pericardium after rapid glutaraldehyde-stabilization versus multistep ADAPT(R) treatment in a subcutaneous rat model.
Neethling W; Brizard C; Firth L; Glancy R
Eur J Cardiothorac Surg; 2014 Apr; 45(4):e110-7. PubMed ID: 24431173
[TBL] [Abstract][Full Text] [Related]
7. Feasibility evaluation of a new pericardial bioprosthesis with dye mediated photo-oxidized bovine pericardial tissue.
Bianco RW; Phillips R; Mrachek J; Witson J
J Heart Valve Dis; 1996 May; 5(3):317-22. PubMed ID: 8793684
[TBL] [Abstract][Full Text] [Related]
8. Curcumin-crosslinked acellular bovine pericardium for the application of calcification inhibition heart valves.
Liu J; Li B; Jing H; Qin Y; Wu Y; Kong D; Leng X; Wang Z
Biomed Mater; 2020 May; 15(4):045002. PubMed ID: 31972553
[TBL] [Abstract][Full Text] [Related]
9. A novel tissue treatment to reduce mineralization of bovine pericardial heart valves.
Meuris B; De Praetere H; Strasly M; Trabucco P; Lai JC; Verbrugghe P; Herijgers P
J Thorac Cardiovasc Surg; 2018 Jul; 156(1):197-206. PubMed ID: 29572021
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of PVPAC-treated bovine pericardium: a potential replacement for glutaraldehyde in biological heart valves.
Barros JA; Filippin-Monteiro FB; de Oliveira EM; Campa A; Catalani LH; Pitombo Rde N; Polakiewicz B
J Biomed Mater Res B Appl Biomater; 2014 Apr; 102(3):574-82. PubMed ID: 24123957
[TBL] [Abstract][Full Text] [Related]
11. Heparinized bovine pericardium as a novel cardiovascular bioprosthesis.
Lee WK; Park KD; Han DK; Suh H; Park JC; Kim YH
Biomaterials; 2000 Nov; 21(22):2323-30. PubMed ID: 11026639
[TBL] [Abstract][Full Text] [Related]
12. Biocompatibility and calcification of bovine pericardium employed for the construction of cardiac bioprostheses treated with different chemical crosslink methods.
Jorge-Herrero E; Fonseca C; Barge AP; Turnay J; Olmo N; Fernández P; Lizarbe MA; García Páez JM
Artif Organs; 2010 May; 34(5):E168-76. PubMed ID: 20633147
[TBL] [Abstract][Full Text] [Related]
13. A novel anti-calcification strategy of bovine pericardium using sodium bisulfite modification.
Zhou J; Jiang H; Wang D; Hu S
J Heart Valve Dis; 2009 Mar; 18(2):180-5; discussion 186. PubMed ID: 19455893
[TBL] [Abstract][Full Text] [Related]
14. Impact of glutaraldehyde on calcification of pericardial bioprosthetic heart valve material.
Grabenwöger M; Sider J; Fitzal F; Zelenka C; Windberger U; Grimm M; Moritz A; Böck P; Wolner E
Ann Thorac Surg; 1996 Sep; 62(3):772-7. PubMed ID: 8784007
[TBL] [Abstract][Full Text] [Related]
15. In vivo study of lyophilized bioprostheses: 3 month follow-up in young sheep.
Taniguchi FP; Maizato MJ; Ambar RF; Pitombo RN; Leiner AA; Moreira LF; Cestari IA; Stolf NA
Rev Bras Cir Cardiovasc; 2012 Dec; 27(4):592-9. PubMed ID: 23515732
[TBL] [Abstract][Full Text] [Related]
16. In search of the best xenogeneic material for a paediatric conduit: an experimental study.
Zhuravleva IY; Nichay NR; Kulyabin YY; Timchenko TP; Korobeinikov AA; Polienko YF; Shatskaya SS; Kuznetsova EV; Voitov AV; Bogachev-Prokophiev AV; Karaskov AM
Interact Cardiovasc Thorac Surg; 2018 May; 26(5):738-744. PubMed ID: 29346675
[TBL] [Abstract][Full Text] [Related]
17. [Calcification mechanism and anticaicification on cardial bioprostheses].
Yi D; Liu W; Yang J
Zhonghua Wai Ke Za Zhi; 1996 Oct; 34(10):631-3. PubMed ID: 9590744
[TBL] [Abstract][Full Text] [Related]
18. Effect of SDS-based decelullarization in the prevention of calcification in glutaraldehyde-preserved bovine pericardium: study in rats.
Collatusso C; Roderjan JG; Vieira ED; Costa FD; Noronha Ld; Fornazari Dde F
Rev Bras Cir Cardiovasc; 2012; 27(1):88-96. PubMed ID: 22729305
[TBL] [Abstract][Full Text] [Related]
19. Effects of glutaraldehyde concentration and fixation time on material characteristics and calcification of bovine pericardium: implications for the optimal method of fixation of autologous pericardium used for cardiovascular surgery.
Lee C; Lim HG; Lee CH; Kim YJ
Interact Cardiovasc Thorac Surg; 2017 Mar; 24(3):402-406. PubMed ID: 28011740
[TBL] [Abstract][Full Text] [Related]
20. Calcification of bovine pericardium: glutaraldehyde versus No-React biomodification.
Abolhoda A; Yu S; Oyarzun JR; McCormick JR; Bogden JD; Gabbay S
Ann Thorac Surg; 1996 Jul; 62(1):169-74. PubMed ID: 8678638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
